Thursday, October, 17, 2019 10:09:15

GSK to acquire the Massachusetts-based biopharmaceutical firm TESARO

British pharmaceutical company, GlaxoSmithKline plc (GSK) has recently entered into a definitive agreement to acquire Massachusetts’ oncology-focused pharmaceutical firm, TESARO, Inc. for an aggregate cash consideration of about $5.1 billion (£4.0 billion). Sources suggest that the proposed deal will significantly strengthens GSK’s pharmaceutical division by …

ResMed plans to purchase digital therapeutics firm Propeller Health

ResMed, a market leader in cloud-based medical equipment & out-of-hospital SaaS solutions, has reportedly declared that it has entered into a definitive agreement for acquiring Propeller Health. The latter apparently, is a digital therapeutics firm offering connected healthcare solutions to people suffering from asthma and …

Thales uplifts its presence in APAC with digital center in Singapore

Thales Group, a France-based multinational aerospace and technology company, has reportedly announced the inclusion of Singapore into its digital factory network. Reportedly, Singapore is the third country welcoming the Thales Digital Factory, after France and Canada. For those uninitiated, Thales Digital Factory is an IT …

Biocartis ties up with AstraZeneca to speed up lung cancer diagnostics

The renowned molecular diagnostics company based in Belgium, Biocartis Group, has reportedly entered into an agreement with the British biopharmaceutical company, AstraZeneca to accelerate the use of lung cancer molecular diagnostic biomarker results across Europe. In accordance with the recent agreement, the Belgian molecular diagnostic …